오가노이드사이언스

476040KOSDAQ자연과학 및 공학 연구개발업

47.6 / 100

Reference Date: 2026-07-24

Financial Score14.5 / 40

News Sentiment19.1 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is undervalued vs. peers but the high debt ratio poses financial risk. Plunged 23.9% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Organoid Science is a biotech company developing regenerative therapies and material evaluation solutions based on organoid technology, including the refractory intestinal ulcer treatment ATORM-C and the ODISEI platform. The company is expanding into precision medicine, customized research reagents, and CDMO services, leveraging its advanced technology recognized as a national strategic innovation in 2023.

Number of Employees

89people

Average Salary

53.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 43.644.0Point

PBR

2.03Industry Average 2.524.0Point

In line with industry avg

ROE

-78.43Industry Average -32.093.5Point

2.4x industry avg (excellent)

Debt Ratio

19.43Industry Average 7.310.0Point

2.7x industry avg (risky)

Trend 3.0 / 10 points

Revenue Growth Rate

1.5 / 3

Operating Profit Growth Rate

1.5 / 3

ROE Trend

0.0 / 4

Detailed News Sentiment

4 totalPositive 3Neutral 1Negative 0Average Sentiment Score 76.2

Positive
오가노이드사이언스, 日과 ‘장 오가노이드 재생치료제’ 공동개발
오가노이드사이언스의 일본 대학과의 장 오가노이드 재생치료제 공동개발 소식으로 긍정적인 시장 반응 예상.
Positive
오가노이드 "정부 연구과제 선정…日과 공동개발"
오가노이드사이언스의 장 오가노이드 재생치료제 공동개발 소식으로 인해 긍정적인 시장 반응 예상.
Positive
오가노이드사이언스-화순전남대병원, 오가노이드 뱅크 구축 협력
화순전남대병원과의 협력으로 종양 오가노이드 뱅크 구축이 이루어져 정밀의료 플랫폼 고도화에 기여, 기업의 연구 역량 강화.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 7,650Won52-week high 44,60052-week low 7,370

1-month return0.0Point

1m -23.88% (strong drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0